IART - Company ID 0000917520
The table below shows INTEGRA LIFESCIENCES HOLDINGS CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $391.92M | $402.06M | $415.61M | $382.65M | $380.83M | $418.18M |
| Cost of revenue | $174.94M | $195.07M | $206.27M | $188.22M | $180.60M | $192.26M |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
INTEGRA LIFESCIENCES HOLDINGS CORP reported annual revenue of $1.64B for fiscal year 2025. That is up 1.5% from $1.61B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $992.08M (FY 2016) to $1.64B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $178.24M |
| $169.05M |
| $179.89M |
| $181.50M |
| $177.19M |
| $195.47M |
| Operating income | $11.47M | $11.76M | -$512.67M | -$15.50M | -$8.15M | -$3.03M |
| Income tax | $2.21M | -$1.42M | -$46.88M | -$4.74M | -$9.67M | -$2.78M |
| Net income | -$4.62M | -$5.40M | -$484.07M | -$25.29M | -$10.70M | -$12.40M |
| EPS (diluted) | -$0.06 | -$0.07 | -$6.31 | -$0.33 | -$0.14 | -$0.16 |